Baillie Gifford Shin Nippon PLC (BGS) — Investment Research Note

Executive summary

Baillie Gifford Shin Nippon is a London-listed investment trust holding a concentrated portfolio (~65 names) of small-cap Japanese growth equities, predominantly internet/SaaS, niche industrials, and consumer companies. The headline operating trajectory across the five-year period has been brutal: NAV total return is down ~23% over five years and down ~13% over three years, vs. the MSCI Japan Small Cap index up 46% and 31% respectively — a cumulative ~70pp of relative underperformance driven by the post-2021 derating of growth small-caps 2025-09 half-year. The single most important valuation input today is the persistent discount to NAV (10.8% at 31 July 2025) combined with the embedded "double discount" the manager flags — portfolio companies trading at a forward P/E near a decade low relative to the index 2025-09 half-year.

Fair value estimate

• Methodology: Net Asset Value (NAV) with the discount-to-NAV as the primary swing factor. This is the standard approach for closed-end investment trusts and the only defensible methodology given that the "company" is a portfolio of marketable securities.
• Inputs:
  • NAV per share at 31 July 2025: 143.4p (borrowings at fair value) 2025-09 half-year
  • 256.4m shares in issue post-buybacks (8.3% of share count repurchased in H1)
  • Current share price implied by £293.7m market cap ÷ 256.4m shares ≈ 114.5p (some divergence from the 128p July close — likely reflecting a wider discount and/or NAV drift since reporting)
• Fair value range: I anchor on 125p – 145p, equivalent to a 12% discount (in line with the 12-month trailing average) on the low end and NAV-flat on the high end. This translates to a market cap range of £320m – £372m.
• Mid-point: ~135p / £346m.
• vs. £293.7m current market cap: +18% absolute upside to the mid-point, +27% to the high end, +9% to the low end.
• Note on conviction in the NAV itself: 96% of total assets are Level 1 listed Japanese equities valued daily at quoted prices — this is a highly reliable NAV. Only ~2% sits in Level 3 private holdings (Gojo, Spiber, Moneytree, JEPLAN — two of which have been written down materially in the past year) 2025-09 half-year.

Sector context

• Sector classification: Financial Services (ICB) — confirmed; this is a UK-listed closed-end investment trust.
• Quality/growth/leverage profile vs. peers: Quality is mid — manager has a strong long-term franchise (Baillie Gifford) but the lead PM was replaced mid-2025 after sustained underperformance 2025-09 half-year. Growth profile is the most aggressive in the UK-listed Japan small-cap segment. Balance-sheet gearing of 15.8% (¥14.84bn yen-denominated loans) is above peer averages for investment trusts but standard for the trust.
• Listed peers: AVI Japan Opportunity Trust (AJOT), Nippon Active Value Fund (NAVF), JPMorgan Japan Small Cap Growth & Income (JSGI), Atlantis Japan Growth Fund (AJG). Shin Nippon is the only pure-play growth Japan small-cap trust 2025-04 annual.

Investment thesis

1. Trading at double discount with a credible NAV anchor. Share price at a 10.8% discount to a Level-1-dominated NAV, while the underlying portfolio itself trades at a forward P/E "at near the lowest level in a decade" relative to the benchmark 2025-09 half-year. Active 8.3% share-count reduction in H1 alone, plus a newly-created distributable reserve (Court of Session approval August 2025) provides ammunition for sustained buybacks 2025-09 half-year.
2. Performance-triggered tender backstop. The Board has committed to a one-off tender offer for up to 15% of issued share capital at a 2% discount to NAV if the trust underperforms the index over the three years to 31 January 2027. Currently trailing the index by 19.4%, with 18 months left — making the tender highly likely to trigger, capping downside 2025-09 half-year, src: 2024-03 annual.
3. Portfolio reshaped under new PM with broader mandate. New lead PM Brian Lum (promoted September 2025) and recently lifted ¥150bn market-cap restriction give a wider opportunity set; recent additions include DMG Mori, Money Forward — better-quality compounders previously excluded. Manager flags improving Japan macro: yen strengthening, monetary policy normalising, US-Japan trade negotiations resolved 2025-09 half-year.

Key risks

1. Sustained underperformance triggers the tender, but the wider problem remains. Tender caps near-term downside but does nothing to fix the underlying performance gap. NAV is down 13.4% over three years vs. index up 30.8% 2025-09 half-year. If small-cap Japan growth remains out of favour, the discount could re-widen post-tender.
2. Concentrated, illiquid, gearing-amplified portfolio. £74.5m yen-denominated loans = 20% gross gearing. In a sharp drawdown (e.g. FY2024: portfolio fell ~£98m), gearing magnifies losses. Two unlisted holdings (Spiber, JEPLAN) suffered ~80%+ valuation write-downs in FY2025 due to funding crises, illustrating the tail risk in the unlisted bucket 2025-04 annual.
3. AI exposure is indirect at best; some holdings face AI disruption risk. The manager's commentary on AI is observational, not financial — they mention AI is "compressing product development timelines" but the trust does not have material picks-and-shovels exposure. Holdings like Crowdworks (crowd-sourcing labour), Bengo4.com (online legal), Vector (PR), and Technopro (IT staffing) are arguably AI-substitution targets, not beneficiaries [inferred from holdings list].

Operating leverage

For an investment trust, the relevant "operating leverage" concept is twofold:

• Trust-level cost structure: Ongoing charges 0.80% on a £367m NAV base; the fee schedule is tiered (0.75% on first £50m, 0.65% on next £200m, 0.55% thereafter), so trust-level operating leverage to NAV growth is modest — incremental NAV at the margin earns a fee margin of ~80-90bps on the saved spread, with admin costs essentially fixed at ~£700k p.a. 2025-09 half-year.
• Look-through to portfolio companies: Several holdings have genuine operating leverage flagged in commentary — Cybozu raised prices and saw "operating leverage coming through" with strong margin expansion 2025-09 half-year; SWCC, Bengo4.com, Infomart all repriced and saw margin expansion 2025-04 annual; SpiderPlus expected to flip to profitability after years of growth investment 2024-03 annual. However, the investor cannot capture this directly — only through NAV appreciation if the manager picks winners and the market rerates them. This is a poor vehicle for the user's "long-tail of operating leverage" thesis because: (a) gearing amplifies both directions; (b) NAV is the average of ~65 stocks; (c) any portfolio-company operating-leverage windfall is diluted across the basket.

Value-trap signals

• Five-year and three-year share price total returns negative (-29.4% and -17.5%) against a positive index, suggesting structural rather than cyclical underperformance 2025-09 half-year.
• PM replacement after extended underperformance — signals the Board's loss of confidence and acknowledges process issues, even as the philosophy is unchanged 2025-09 half-year.
• Two unlisted holdings written down ~80-85% in FY2025 (Spiber, JEPLAN) due to funding crises — raises questions about the valuation rigour and risk monitoring of the private bucket 2025-04 annual.
• The Chair's own statement: "patience in some quarters is being tested … if poor performance continues … the Board will not hesitate to assess all available options" 2025-09 half-year — frank but flags risk of structural change (potentially wind-up or merger) rather than recovery.

Earnings vs. expectations

Investment trusts do not "beat or miss" earnings in the traditional sense; the relevant analogue is NAV vs. benchmark.

• FY 2023 (year to Jan 2023): NAV -1.2% vs. index +5.7% — miss.
• FY 2024 (year to Jan 2024): NAV -14.9% vs. index +6.3% — substantial miss.
• FY 2025 (year to Jan 2025): NAV -5.1% vs. index +8.9% — substantial miss.
• H1 FY2026 (year to Jul 2025): NAV +3.4% vs. index +7.9% — miss but narrowing.

Pattern: Consistent, multi-year underperformance against the comparative benchmark. Recent narrowing in H1 2025 is encouraging but trails the index by 19.4% over the tender-measurement period to date.

Conviction

Conviction: 4 (high) in the fair-value range stated.

Anchors: (i) NAV is Level-1, daily-priced, and audited — very low risk of the asset values being wrong; (ii) the discount-to-NAV framework is mechanical and well-understood for closed-end trusts; (iii) the performance-triggered tender provides a contractual cap on the discount.

Caveats: (i) The discount itself is a moving variable and could re-widen if the trust fails to outperform over the next 18 months; (ii) yen/sterling FX moves and the gearing position introduce volatility I'm not modelling explicitly.